Overview
David Ginsburg is a Hematologist practicing medicine in Ann Arbor, Michigan.
Dr. Ginsburg is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Mesenteric Venous Thrombosis, Von Willebrand Disease (VWD), Congenital Hemolytic Anemia, and Blood Clots.
He is actively involved in clinical research, co-authoring 90 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
1500 E Medical Center Dr, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rogel Cancer Center
Rashmi Chugh is an Oncologist and a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.
Rogel Cancer Center
The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is highly rated in 24 conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Wilcox is currently accepting new patients.
C. S. Mott Children's Hospital
Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology. Dr. Bixby is currently accepting new patients.
Rogel Cancer Center
Dr. Sahai is the Leader of the Gastrointestinal Medical Oncology Section and Associate Professor in the Division of Hematology-Oncology, Department of Internal Medicine. Dr. Sahai is also a member of the University of Michigan Rogel Cancer Center and Director of Tumor Response Assessment Core.Dr. Sahai attended medical school at the Government Medical College at Amritsar with the Baba Farid University of Health Science in India. He then completed his Masters in Clinical Epidemiology at Harvard School of Public Health followed by Internal Medicine residency training at University of Pittsburgh where he met his wife. He completed his fellowship in Hematology-Oncology at Northwestern University where he also served as the Chief Fellow. Subsequently, Dr. Sahai joined University of Michigan as Assistant Professor in Internal Medicine in 2013.Dr. Sahai is a clinician-scientist who sees patients within the Multidisciplinary Pancreatic and Liver Tumor programs. As a clinical investigator he is the Principal Investigator on several investigator-initiated clinical trials open across the U.S. His translational research program leverages the pancreaticobiliary cancer biobanks that he directs for the therapeutic investigation of novel compounds in patient-derived cell lines and xenograft models to help develop novel phase 1/2 investigator-initiated clinical trials. Dr. Sahai is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, and Neuroendocrine Tumor. Dr. Sahai is currently accepting new patients.
Rogel Cancer Center
Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Hematology and Internal Medicine. Dr. Campagnaro is currently accepting new patients.
Frequently Asked Questions about Dr. David M. Ginsburg
How do I make an appointment with Dr. David M. Ginsburg?
You can book an appointment with Dr. David M. Ginsburg by calling their office at 734-763-2532. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. David M. Ginsburg a top-rated expert for Mesenteric Venous Thrombosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. David M. Ginsburg is classified as an Advanced expert for Mesenteric Venous Thrombosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. David M. Ginsburg specialize in?
While Dr. David M. Ginsburg is a Hematology, they have specific expertise in Mesenteric Venous Thrombosis, Von Willebrand Disease (VWD), and Congenital Hemolytic Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. David M. Ginsburg participate in research or clinical trials?
Yes. Dr. David M. Ginsburg has published 90 articles and abstracts on conditions like Mesenteric Venous Thrombosis. You can view a list of Dr. David M. Ginsburg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. David M. Ginsburg accept my insurance?
Dr. David M. Ginsburg accepts most major insurance plans, including Humana. We recommend calling the office directly at 734-763-2532 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AnemiaDr. Ginsburg isAdvanced. Learn about Anemia.
- Blood ClotsDr. Ginsburg isAdvanced. Learn about Blood Clots.
- Congenital Hemolytic AnemiaDr. Ginsburg isAdvanced. Learn about Congenital Hemolytic Anemia.
- Hemolytic AnemiaDr. Ginsburg isAdvanced. Learn about Hemolytic Anemia.
- Mesenteric Venous ThrombosisDr. Ginsburg isAdvanced. Learn about Mesenteric Venous Thrombosis.
- Von Willebrand Disease (VWD)Dr. Ginsburg isAdvanced. Learn about Von Willebrand Disease (VWD).
- Experienced
- Alpha ThalassemiaDr. Ginsburg isExperienced. Learn about Alpha Thalassemia.
- Deep Vein ThrombosisDr. Ginsburg isExperienced. Learn about Deep Vein Thrombosis.
- HemoglobinopathyDr. Ginsburg isExperienced. Learn about Hemoglobinopathy.
- Pulmonary EmbolismDr. Ginsburg isExperienced. Learn about Pulmonary Embolism.
- ThalassemiaDr. Ginsburg isExperienced. Learn about Thalassemia.
- ThrombocytopeniaDr. Ginsburg isExperienced. Learn about Thrombocytopenia.
- Venous Thromboembolism (VTE)Dr. Ginsburg isExperienced. Learn about Venous Thromboembolism (VTE).




